We are live on ! Find out more
First Manhattan

First Manhattan Portfolio holdings

AUM $36.1B
1-Year Est. Return 11.5%
This Fund
S&P 500
This Quarter Est. Return
-0.07%
1 Year Est. Return
+11.5%
3 Year Est. Return
+74.65%
5 Year Est. Return
+103.66%
10 Year Est. Return
+354.63%
AUM
$27.1B
AUM Growth
-$250M
Cap. Flow
+$8.92M
Cap. Flow %
0.03%
Top 10 Hldgs %
55.27%
Holding
1,748
New
132
Increased
271
Reduced
387
Closed
93

Top Buys

Rank Stock Value
1
PPLI
People Inc
PPLI
+$92.9M
2
AMZN icon
Amazon
AMZN
+$62.6M
3
ENTA icon
Enanta Pharmaceuticals
ENTA
+$46.3M
4
VMEO
Vimeo
VMEO
+$33.1M
5
UNH icon
UnitedHealth
UNH
+$28M

Top Sells

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$49.9M
2
BRK.A icon
Berkshire Hathaway Class A
BRK.A
+$43.5M
3
HUM icon
Humana
HUM
+$36.6M
4
VIPS icon
Vipshop
VIPS
+$35.6M
5
BN icon
Brookfield
BN
+$24M

Sector Composition

Rank Sector Weight
1 Financials 41.6%
2 Technology 16.13%
3 Healthcare 10.46%
4 Consumer Discretionary 9.11%
5 Communication Services 8.73%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MFGP
1726
DELISTED
Micro Focus International plc. American Depositary Shares, each representing One Ordinary Share
MFGP
$0 ﹤0.01%
42
-44
-51% -$248
CTIC
1727
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
$0 ﹤0.01%
33
SBNY
1728
DELISTED
Signature Bank
SBNY
-15
Closed -$3K
WLL
1729
DELISTED
Whiting Petroleum Corporation
WLL
$0 ﹤0.01%
4
BDSI
1730
DELISTED
BioDelivery Sciences International, Inc.
BDSI
-500
Closed -$1K
GRA
1731
DELISTED
W.R. Grace & Co.
GRA
-145,340
Closed -$10M
INTZ
1732
DELISTED
INTRUSION INC NEW
INTZ
-400
Closed -$6K

Similar funds

First Manhattan's Q3 2021 Portfolio in Review

As of Q3 2021, First Manhattan held 1,748 positions worth $27.1B, down 0.91% from $27.4B the previous quarter. Its ten largest holdings account for 55% of the portfolio.

First Manhattan's Q3 2021 filing shows 132 new, 271 increased, 387 reduced and 93 closed positions. Its largest new stake was Immunocore: 197,999 shares worth $7.34M. The largest sale was Amgen, an estimated $49.9M.

By sector, the portfolio is most concentrated in Financials at 42% of assets, down from 42% a quarter earlier, followed by Technology and Healthcare.

  • First Manhattan's largest Q3 2021 buy was Immunocore: 197,999 shares worth $7.34M.
  • First Manhattan added most to People Inc in Q3 2021, an estimated $92.9M increase.
  • First Manhattan's biggest Q3 2021 reduction was Amgen, cutting an estimated $49.9M.
  • First Manhattan fully exited Humana in Q3 2021, selling an estimated $36.6M.
  • First Manhattan's ten largest holdings make up 55% of its $27.1B portfolio in Q3 2021.
  • First Manhattan opened 132 new positions and closed 93 in Q3 2021.
  • First Manhattan's portfolio value fell 0.91% quarter-over-quarter to $27.1B.

Based on First Manhattan's 13F filing for Q3 2021, filed 15 Nov 2021.